Каждую осень укол "от всего" Введут в календарь прививок и дело в дамках.Moderna starts mRNA flu vaccine trialsModerna Inc. has begun human trials of an messenger RNA-based seasonal flu vaccine, in a move that could pave the way for a combination shot for adults that could stave off flu, COVID-19 variants and a third common respiratory virus.In a statement, the company said it had begun a combined phase 1 and 2 trial of an mRNA-based vaccine against four influenza strains in roughly 180 adults ages 18 and up. The study will evaluate safety and the immune response, according to the statement.The hope is that the speed and adaptability of mRNA technology will improve efficacy of existing flu vaccines based on older technologies. Existing seasonal flu shots are typically 40 per cent to 60 per cent effective.“Our vision is to develop an mRNA combination vaccine so that people can get one shot each fall for high efficacy protection against the most problematic respiratory viruses,” said Stephane Bancel, Moderna’s chief executive officer, in the statement.